Role of ATP-binding cassette transporter A1 in suppressing lipid accumulation by glucagon-like peptide-1 agonist in hepatocytes
ConclusionsOur data reveals that exendin-4 stimulates hepatic ABCA1 expression and reduces lipid accumulation by the CaMKK/CaMKIV/PREB pathway, suggesting that ABCA1 and PREB might be the therapeutic targets in fatty liver disease.Graphical abstract
Source: Molecular Metabolism - Category: Endocrinology Source Type: research
More News: Cholesterol | Diabetes | Diets | Endocrinology | Fatty Liver Disease (FLD) | Genetics | High Fat | Liver | Liver Disease | Nutrition | Urology & Nephrology